Trial intelligence / Profile preview

Epidural vs General Anesthesia for Pancreaticoduodenectomy

NCT03434678Phase 3Completed

Sponsor
Memorial Sloan Kettering Cancer Center
Start
Jan 2018
Primary completion
Jul 2024
Countries
1
01

Overview

Phase 3, randomised, open-label trial (2 arms), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Number of Incidences of Grade 3 or Greater Complications at 90 days. Started Jan 2018; status: completed.

Beyond the preview

Go deeper on NCT03434678.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03434678.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call